5Goetzl EJ, Dolezalova H, Kong Y, et al. Distinctive expression and functions of the type4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer[ J]. Cancer Res , 1999,59:5370-5375.
6Sasagawa T, Okita M, Murakami J, et al. Abnormal serum lysophospholipids in multiple myeloma patients[ J ]. Lipids , 1999,34:17-21.
7Xiao Y J, Chen YH, Kennedy AW, et al. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses[ J]. Ann NY Acad Sci,2000,905 :243-259.
8Saulnier-Blache JS, Girard A, Simon MF, et al. A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification[ J]. J Lipid Res,2000,41:1947-1951.
9Chen JH, Zou F, Wang ND, et al. Production and application of LPA polyclonal antibody [ J]. Bioorg Med Chem Lett, 2000, 10:1691-1693.
10Chen YL, Xu Y. Determination of lysophosphatidic acids by capillary electrophoresis with indirect ultraviolet detection[ J]. J Chromatogr B Biomed Sci Appl, 2001,753:355-363.
5Gueguen G, Gaige B, Grevy JM, et al. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation[J]. Biochemistry, 1999,38 (26): 8400-8450.
6黎磊石,刘志红主编.中国肾脏病学[M].北京:人民军医出版社,2008,1328-1338
7Shida D, Kitayama J, Yamaguchi H, et al. Lysophosphatidic Acid(LPA) Enhances the Metastic Potential of Human Colon Carcinoma DLD1 Cells Through LPA1[J]. Cancer Res, 2003, 63 : 1706-1711.
8Shida D, Watanabe T, Aoki K, et al. Aberrant Expression of Lysophosphatidic Acid(LPA) Receptors in Human Colorectal Cancer[J]. Lab Invest,2004,84 : 1352-1362.
9Yamaguchi H, Kitayama J, Takuwa N, et al. Sphingosine-1- phosphate Receptor Subtype-specific Positive and Negative Regulation of Rac and Hematogenous Metastasis of Melanoma Cells[J]. Bioehem J, 2003,374 : 715-722.
10Mills G B, Moolenaar W H. The Emerging Role fo Lysophosphatidic Acid in Cancer[J]. Nat Rev Cancer, 2003,3 : 582-591.
